EMPHYSEMA
Clinical trials for EMPHYSEMA explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA trials appear
Sign up with your email to follow new studies for EMPHYSEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a higher dose of this infusion save lungs in Alpha-1 patients?
Disease control Not yet recruitingThis study tests three different doses of a weekly IV medicine (Respreeza/Zemaira) in 270 adults with emphysema caused by Alpha-1 antitrypsin deficiency. The goal is to see which dose best slows the yearly loss of lung density over 3 years. Participants must be 18-65 and have a c…
Matched conditions: EMPHYSEMA
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New scan could boost success of lung valves for emphysema patients
Disease control Not yet recruitingThis study tests whether using a special scan (VQDI) to pick the lung area for valve placement works better than the usual CT-based method. About 285 people with severe emphysema will be randomly assigned to one of two strategies. The goal is to see which approach leads to better…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Could a gene mutation explain unexplained emphysema?
Knowledge-focused Not yet recruitingThis study looks at whether changes in the FLNA gene are linked to emphysema, a lung condition that causes breathing problems. Researchers will examine 70 people with FLNA mutations using lung tests, heart ultrasound, and chest scans. The goal is to find out how common emphysema …
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 04:39 UTC